Tsukasa Morii

1.8k total citations
29 papers, 1.3k citations indexed

About

Tsukasa Morii is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Physiology. According to data from OpenAlex, Tsukasa Morii has authored 29 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Nephrology and 9 papers in Physiology. Recurrent topics in Tsukasa Morii's work include Chronic Kidney Disease and Diabetes (9 papers), Diabetes Treatment and Management (9 papers) and Pancreatic function and diabetes (5 papers). Tsukasa Morii is often cited by papers focused on Chronic Kidney Disease and Diabetes (9 papers), Diabetes Treatment and Management (9 papers) and Pancreatic function and diabetes (5 papers). Tsukasa Morii collaborates with scholars based in Japan, United States and Canada. Tsukasa Morii's co-authors include Hiroki Fujita, Takuma Narita, Yuichiro Yamada, Hiromi Fujishima, Takehiro Sato, Masafumi Kakei, Mihoko Hosoba, Seiki Ito, Takamune Takahashi and Tatsunori Shimizu and has published in prestigious journals such as Nature Medicine, Diabetes Care and Biochemical and Biophysical Research Communications.

In The Last Decade

Tsukasa Morii

28 papers receiving 1.3k citations

Peers

Tsukasa Morii
Tsukasa Morii
Citations per year, relative to Tsukasa Morii Tsukasa Morii (= 1×) peers Hiromi Fujishima

Countries citing papers authored by Tsukasa Morii

Since Specialization
Citations

This map shows the geographic impact of Tsukasa Morii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsukasa Morii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsukasa Morii more than expected).

Fields of papers citing papers by Tsukasa Morii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsukasa Morii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsukasa Morii. The network helps show where Tsukasa Morii may publish in the future.

Co-authorship network of co-authors of Tsukasa Morii

This figure shows the co-authorship network connecting the top 25 collaborators of Tsukasa Morii. A scholar is included among the top collaborators of Tsukasa Morii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsukasa Morii. Tsukasa Morii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimizu, Tatsunori, Shunsuke Kato, T. Sato, et al.. (2024). Recurrent nocturnal hypoglycemic hemiplegia: a case report and review of the literature. Endocrine Journal. 71(4). 409–416.
2.
Kato, Shunsuke, et al.. (2022). Cases of fulminant type 1 and type 2 diabetes mellitus whose HbA1c levels were unmeasurable due to increased labile HbA1c. Diabetology International. 13(4). 698–703. 1 indexed citations
3.
Kato, Shunsuke, Tatsunori Shimizu, Takehiro Sato, et al.. (2020). Sodium-glucose cotransporter 2 inhibition attenuates protein overload in renal proximal tubule via suppression of megalin O-GlcNacylation in progressive diabetic nephropathy. Metabolism. 113. 154405–154405. 29 indexed citations
4.
Sato, Takehiro, Tatsunori Shimizu, Shunsuke Kato, et al.. (2019). Inhibition of GIP signaling extends lifespan without caloric restriction. Biochemical and Biophysical Research Communications. 513(4). 974–982. 7 indexed citations
5.
Kondo, Manabu, Katsuya Tanabe, Masayuki Hatanaka, et al.. (2018). Activation of GLP-1 receptor signalling alleviates cellular stresses and improves beta cell function in a mouse model of Wolfram syndrome. Diabetologia. 61(10). 2189–2201. 47 indexed citations
6.
Takashima, Satoru, Hiroki Fujita, Hiromi Fujishima, et al.. (2016). Stromal cell–derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy. Kidney International. 90(4). 783–796. 85 indexed citations
7.
Fujita, Hiroki, Tsukasa Morii, Hiromi Fujishima, et al.. (2013). The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential. Kidney International. 85(3). 579–589. 273 indexed citations
8.
Fujita, Hiroki, Hiromi Fujishima, Keiko Takahashi, et al.. (2012). SOD1, but not SOD3, deficiency accelerates diabetic renal injury in C57BL/6-Ins2 diabetic mice. Metabolism. 61(12). 1714–1724. 32 indexed citations
9.
Narita, Takuma, Hiroki Yokoyama, Takehiro Sato, et al.. (2011). Comparisons of the effects of 12‐week administration of miglitol and voglibose on the responses of plasma incretins after a mixed meal in Japanese type 2 diabetic patients. Diabetes Obesity and Metabolism. 14(3). 283–287. 62 indexed citations
10.
Fujita, Hiroki, Takuya Sakamoto, Koga Komatsu, et al.. (2011). Reduction of circulating superoxide dismutase activity in type 2 diabetic patients with microalbuminuria and its modulation by telmisartan therapy. Hypertension Research. 34(12). 1302–1308. 25 indexed citations
11.
Fujita, Hiroki, Hiromi Fujishima, Tsukasa Morii, et al.. (2011). Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2Akita diabetic mice. Hypertension Research. 35(2). 213–220. 43 indexed citations
13.
Hosoba, Mihoko, Hiroki Fujita, Toshiyuki Miura, et al.. (2009). Diurnal Changes in Urinary Excretion of IgG, Transferrin, and Ceruloplasmin Depend on Diurnal Changes in Systemic Blood Pressure in Normotensive, Normoalbuminuric Type 2 Diabetic Patients. Hormone and Metabolic Research. 41(12). 910–915. 9 indexed citations
14.
Narita, Takuma, Mihoko Hosoba, Toshiyuki Miura, et al.. (2008). Low Dose of Losartan Decreased Urinary Excretions of IgG, Transferrin, and Ceruloplasmin without Reducing Albuminuria in Normoalbuminuric Type 2 Diabetic Patients. Hormone and Metabolic Research. 40(4). 292–295. 6 indexed citations
15.
Fujita, Hiroki, Jun Koshimura, Takehiro Sato, et al.. (2007). Effects of Long-Term Pravastatin Treatment on Serum and Urinary Monocyte Chemoattractant Protein-1 Levels and Renal Function in Type 2 Diabetic Patients with Normoalbuminuria. Renal Failure. 29(7). 791–796. 1 indexed citations
16.
Miura, Masatomo, Masafumi Kakei, Tsukasa Morii, et al.. (2007). Assessment of Compliance for Oral Medicines with MMSE, Minimental State Examination, in Hospitalized Elderly Patients. YAKUGAKU ZASSHI. 127(10). 1731–1738. 1 indexed citations
17.
Fujita, Hiroki, Hiromi Fujishima, Jun Koshimura, et al.. (2005). Effects of Antidiabetic Treatment with Metformin and Insulin on Serum and Adipose Tissue Adiponectin Levels in db/db Mice. Endocrine Journal. 52(4). 427–433. 48 indexed citations
18.
Fujita, Hiroki, Hiromi Fujishima, Tsukasa Morii, et al.. (2002). Effect of metformin on adipose tissue resistin expression in db/db mice. Biochemical and Biophysical Research Communications. 298(3). 345–349. 49 indexed citations
19.
Morii, Tsukasa, Hiroki Fujita, Takuma Narita, et al.. (2002). Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. Journal of Diabetes and its Complications. 17(1). 11–15. 150 indexed citations
20.
Fujita, Hiroki, Takuma Narita, Tsukasa Morii, et al.. (2002). INCREASED URINARY EXCRETION OFN-ACETYLGLUCOSAMINIDASE IN SUBJECTS WITH IMPAIRED GLUCOSE TOLERANCE. Renal Failure. 24(1). 69–75. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026